Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 6, 1999, Pages 341-349

  Kizaki, Y ^b   Ueki, Yukitaka ^a   Yoshida, K ^a   Yano, M ^a   Matsumoto, K ^a   Miyake, S ^a   Tominaga, Y ^a   Eguchi, K ^b   Yano, K ^b  

^a SASEBO CHUO HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bradykinin; Heparin; Nafamostat mesilate; Nitric oxide; Peripheral arterial obstructive disease

Indexed keywords

BRADYKININ; HEMOGLOBIN; HEPARIN; LOW DENSITY LIPOPROTEIN; NAFAMSTAT MESILATE; NITRIC OXIDE;

ADSORPTION; ADULT; AGED; APHERESIS; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; FEMALE; HUMAN; MALE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SKIN TEMPERATURE; VASCULAR ENDOTHELIUM;

EID: 0032869002     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199909000-00004     Document Type: Article

References (27)

1. 1. Agishi T, Kitano Y, Suzuki T, Miura A, Murakami J, Minagawa H, et al. Improvement of peripheral circulation by low density lipoprotein adsorption. Asaio Trans 1989; 35: 349-351.
2. 2. Naganuma S, Agishi T, Ota K. Effect of LDL apheresis on lipoprotein (a) levels in arteriosclerotic obliterans. Artificial Organs 1991; 15: 336.
3. 3. Agishi T, Naganuma S, Nakasato S, Kitajima K, Ota K, Ban K, et al. Treatment of arteriosclerotic obstruction by LDL adsorption. Angiology 1993; 44: 222-227.
4. 4. Sato Y, Agishi T. Low-density lipoprotein adsorption for arteriosclerotic patients. Artificial Organs 1996; 20: 324-327.
5. 5. Kojima S, Harada SM, Nomura S, Kimura G, Tsushima M, Kuramochi M, et al. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column. Asaio Trans 1991; 37: 644-648.
6. 6. Yamamoto A, Kojima S, Siba-Harada M, Kawaguchi A, Hatanaka K. Assessment of the biocompatibility and long-term effect of LDL-apheresis by dextran sulfate-cellulose column. Artificial Organs 1992; 16: 177-181.
7. 7. Mombouli JV, Vanhoutte PM. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol 1995; 35: 679-705.
8. 8. Murashima J, Ueki Y, Matsunaga Y, Yano M, Matsumoto K, Miyake S, et al. Removal of LDL from plasma by adsorption increases bradykinin and plasma nitric oxide levels in patients with peripheral atherosclerosis. Blood Coag Fibrinol 1998; 9: 725-732.
9. 9. Koga N, Nagano T, Sato T, Kagasawa K. Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor. Asaio J 1993; 39: M288-M291.
10. 10. Friedewald WT, Levy RI, Friedrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499-504.
11. 11. Minami M, Togashi H, Sano M. Plasma bradykinin concentration in patients with essential hypertension, effort angina and other cardiac diseases. Folia Pharmacol Japon 1983; 82: 159-169.
12. 12. Yamamoto A, Yokoyama S, Satani M, Kikkawa T, Kishino B. Evaluation of selective LDL-removal in the treatment of familial hypercholesterolemia: double membrane filtration and adsorption system. Prog Clin Biol Res 1988; 255: 357-366.
13. 13. Ueki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996; 23: 230-236.
14. 14. Braman RS, Hendrix SA. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Ann Chem 1989; 61: 2715-2718.
15. 15. Jia L, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380: 221-226.
16. 16. Meier HL, Pierce JU, Colman RW, Kaplan AP. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest 1977; 60: 18-31.
17. 17. Heimark RL, Kurachi K, Fujikawa K, Davie EW. Surface activation of blood coagulation, fibrinolysis, and kinin formation. Nature 1980; 286: 456-460.
18. 18. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxations of the arterial smooth muscle by acetylcholine. Nature 1980; 286: 373-376.
19. 19. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 1984; 24: 175-197.
20. 20. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992; 89: 10-18.
21. 21. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546-1550.
22. 22. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997; 95: 76-82.
23. 23. Kojima S, Ogi M, Sugi T, Matsumoto Y, Yoshitomi Y, Kuramochi M. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis. Therapeutic Apheresis 1997; 1: 356-361.
24. 24. Wennmalm A, Benthin G, Edlund A, Jungersten L, Kieler JN, Lundin S, et al. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 1993; 73: 1121-1127.
25. 25. Wennmalm A, Benthin G, Petersson AS. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 1992; 106: 507-508.
26. 26. Kruszyna R, Kruszyna H, Smith RP, Thron CD, Wilcox DE. Nitrite conversion to nitric oxide in red cells and its stabilization as a nitrosylated valency hybrid of hemoglobin. J Pharmacol Exp Ther 1987; 241: 307-313.
27. 27. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 1997; 276: 2034-2037.